Expert Profile
Dennis Weissman
President, Dennis Weissman and Associates LLC
Dennis Weissman, A nationally recognized, independent analyst and thought leader in the diagnostic field for over three decades, Dennis is President of Dennis Weissman & Associates, LLC, Falls Church, VA, a consultancy which provides market intelligence, M&A advisory services, business leadership and public policy advice to diagnostic and life science companies and organizations. He has expertise in Medicare and health care reform policies and trends; clinical lab and pathology payment & compliance policies as well as business trends affecting the diagnostic sector. Dennis founded and served as publisher of Washington G-2 Reports (now G2 Intelligence) through 1999, an information company that reports on and analyzes the U.S. clinical laboratory industry via newsletters, research reports and conferences. Prior to G2, he served as the Director of the Washington Office of the American Society for Medical Technology (now ASCLS) and before that, Special Assistant to the Deputy Assistant Secretary for Health, Department of Health, Education & Welfare (now HHS).
Trainings by Expert
How Medicare's Market-Based Payment System Is Upending the U.S. Clinical Laboratory Market
Category:
Laboratory Compliance
,
Healthcare Compliance (Hospitals)
,
Laboratory
,
HEALTHCARE
,
Hospital Management
,
Audit & Data Security
,
HIPAA
,
Healthcare Regulations
,
Regulatory Affairs
Where FDA Is Heading in Regulating Laboratory-Developed Tests
Category:
Laboratory Compliance
,
Healthcare Compliance (Hospitals)
,
Testing and Validation
,
Quality and Safety
,
Laboratory
,
Clinical Laboratory
,
HEALTHCARE
,
Hospital Management
,
Healthcare Regulations
,
Audit & Inspection-Role
,
Healthcare Audit
,
Lab Audit
,
Documentation and Policy Management
,
Lifescience process & Procedures
,
Life sciences QA/QC
,
Regulations & Guidances
,
Life Sciences
,
Regulatory Affairs
,
Documentation and Data Management
,
QA/QC
The Latest in CLIA Compliance for Clinical Labs
Category:
Laboratory Compliance
,
Quality and Safety
,
Audits & Inspections
,
Laboratory
,
Clinical Laboratory
,
Audit & Inspection-Role
,
Lab Audit
,
Documentation and Policy Management
,
Lifescience process & Procedures
,
Life sciences QA/QC
,
Regulations & Guidances
,
Life Sciences
,
Regulatory Affairs
,
Documentation and Data Management
,
QA/QC
Health Reform Turbulence in the Trump Era: Market Impact and 2018 Outlook
Category:
HEALTHCARE
How Medicare's Market-Based Payment System for Laboratory Services Will Change the Industry's Competitive Dynamics In 2019
Category:
Laboratory
Adopting Price Controls for U.S. Prescription Drugs: Federal Policy Outlook for 2019 and Beyond
Category:
Drugs and Chemicals (Pharma)
The Healthcare Disruptors: Impact Amazon & Other Big Tech Companies Are Having on The Healthcare Industry
Category:
HEALTHCARE
What To Expect From FDA’s New Approach to Regulate Medical Software
Category:
All FDA Regulated Industry
Feds Take New Aim at Prescription Drug Prices: What to Expect from the Biden Administration & Congress
Category:
All FDA Regulated Industry
Federal Oversight of Laboratory-Developed Tests in Limbo: What’s the Regulatory & Legislative Outlook for LDTs?
Category:
All FDA Regulated Industry
